Andrew Adler, DPM
Foot & Ankle Surgery · Matthews, NCNPI 1154813194
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,750 of the $10,183 with a category attached, or 76.1%. IBSA Pharma Inc. accounts for 82.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $6,344 and has fallen 96.2% since, to $241 in 2025.
Across 64 payments — averaging $159.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$8K
- Stryker$594
- Treace Medical Concepts, Inc.$392
- Peerless Surgical Inc.$248
- Johnson & Johnson$182
- Bioventus LLC$86
- plus $278 from 8 others
What the payments were for
- Consulting fees$7,75076%
- Speaking & faculty fees$6006%
- Food & beverage$1,83318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 12 | $8,403 |
| Stryker | 20 | $594 |
| Treace Medical Concepts, Inc. | 7 | $392 |
| Peerless Surgical Inc. | 3 | $248 |
| Johnson & Johnson | 2 | $182 |
| Bioventus LLC | 4 | $86 |
| Smith+Nephew | 4 | $82 |
| GRT US Holding, Inc. | 4 | $56 |
| Sebela Pharmaceuticals Inc. | 3 | $51 |
| Triad Life Sciences Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $20 |
| Convatec Inc. | 1 | $16 |
| Nevro Corp. | 1 | $14 |
| Next Science LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Licart$8,350
- PROstep$278
- Lapiplasty System$193
- HEALIX KNOTLESS PEEK$139
How this compares
$10,183 in reported general payments places this provider in the 80th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 172 | $3,961 |
| Ciclopirox | 121 | $3,550 |
| Colchicine | 27 | $1,621 |
| Methylprednisolone | 141 | $913 |
| Gabapentin | 63 | $552 |
| Meloxicam | 117 | $390 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $389 |
| Terbinafine Hcl | 39 | $332 |
| Doxycycline Hyclate | 28 | $297 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $217 |
| Celecoxib | 17 | $186 |
| Diclofenac Sodium | 21 | $178 |
| Cephalexin | 24 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $98 |
| Tramadol Hcl | 24 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Matthews
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
- Kristen McGinnessFayetteville$123K
- William RespessGreenville$79K
- Brian FutrellCary$71K
- Kenneth BloomMooresville$53K
- Stephen HeislerChapel Hill$49K
- Benjamin UmbelMorganton$37K
- Andrew HanselmanWake Forest$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.